Amazon Pharmacy Expands Access to Weight Management Medication

On March 9, 2026, Amazon.com Inc. (NASDAQ: AMZN) announced a significant enhancement to its Amazon Pharmacy service, unveiling expanded access to Eli Lilly's Zepbound® KwikPen®—a multi-dose injectable treatment aimed at weight management. This strategic move aligns with Amazon Pharmacy's commitment to providing convenient and transparent healthcare solutions to its customers.

The Zepbound KwikPen allows patients to receive a full month's supply of medication in a single device, significantly reducing the number of single-dose devices typically required. With a valid prescription, customers can easily order the Zepbound KwikPen through Amazon Pharmacy. The pricing starts at $299 per month for the 2.5 mg starter dose, allowing customers to view the exact cost before checkout—an initiative that underscores Amazon Pharmacy's dedication to transparent pricing.

Eli Lilly's Zepbound has quickly emerged as one of the most prescribed injectable medications for weight management in the United States. It is particularly effective for adults struggling with obesity and those with moderate-to-severe obstructive sleep apnea. The medication is designed to assist in not only losing weight but also maintaining weight loss when combined with a proper diet and exercise regimen.

"Convenient access to medications and clear, transparent pricing are at the heart of what we do at Amazon Pharmacy," stated Tanvi Patel, Vice President and General Manager of Amazon Pharmacy. Patel emphasized that by expanding access to the Zepbound KwikPen with upfront self-pay pricing, Amazon Pharmacy aims to simplify the process for customers to obtain the treatments prescribed by their healthcare providers, all delivered reliably to their homes.

Since its inception, Amazon Pharmacy has been a pioneer in delivering GLP-1 medications, collaborating with healthcare providers, industry partners, and digital health companies such as LillyDirect, WeightWatchers, UpScriptHealth, and Noom. These partnerships are designed to broaden access to essential weight management treatments.

Additionally, customers benefit from Amazon Pharmacy’s automatic coupon program, which has resulted in over $200 million in savings to date. Notably, GLP-1 medications have emerged as the largest category contributing to these savings, demonstrating Amazon Pharmacy's ability to facilitate affordability in healthcare.

For customers seeking a more holistic approach to weight management, Amazon One Medical offers personalized clinical evaluations, evidence-based treatment recommendations, and ongoing care management. This includes tailored medication prescribing that aligns with individual health needs and goals, creating a comprehensive support system for patients.

Amazon Pharmacy continues to enhance customer experience with free, fast delivery on the first order of each new medication. The service currently offers Same-Day Delivery to nearly 3,000 cities and towns, with plans to expand this coverage to nearly 4,500 locations by the end of 2026. Customers can easily access Amazon Pharmacy through pharmacy.amazon.com or via the Amazon app.

As Amazon Pharmacy continues to innovate and expand its offerings, the introduction of Eli Lilly's Zepbound KwikPen marks another step forward in the company's mission to make healthcare more accessible and transparent. With a focus on customer service and affordability, Amazon is positioning itself as a formidable player in the digital pharmacy landscape, catering to the evolving needs of healthcare consumers.